Display options
Cite
A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients With Advanced Cirrhosis or Posttransplant Recurrence: Phase 3 ALLY-1 Study• Efficacy and Safety of Grazoprevir and Elbasvir in Hepatitis C Genotype 1-Infected Patients With Child-Pugh Cl. Gastroenterol Hepatol (N Y). 2015;11(6):1-23
(2015). A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients With Advanced Cirrhosis or Posttransplant Recurrence: Phase 3 ALLY-1 Study• Efficacy and Safety of Grazoprevir and Elbasvir in Hepatitis C Genotype 1-Infected Patients With Child-Pugh Cl. Gastroenterology & hepatology, 11(6), 1-23.
"A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients With Advanced Cirrhosis or Posttransplant Recurrence: Phase 3 ALLY-1 Study• Efficacy and Safety of Grazoprevir and Elbasvir in Hepatitis C Genotype 1-Infected Patients With Child-Pugh Cl." Gastroenterology & hepatology vol. 11,6 (2015): 1-23.
A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients With Advanced Cirrhosis or Posttransplant Recurrence: Phase 3 ALLY-1 Study• Efficacy and Safety of Grazoprevir and Elbasvir in Hepatitis C Genotype 1-Infected Patients With Child-Pugh Cl. Gastroenterol Hepatol (N Y). 2015 Jun;11(6):1-23. PMID: 26504459; PMCID: PMC4617178.
Copy Download .nbib Format: NLM
Share it on

Gastroenterol Hepatol (N Y). 2015 Jun;11(6):1-23.

A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients With Advanced Cirrhosis or Posttransplant Recurrence: Phase 3 ALLY-1 Study• Efficacy and Safety of Grazoprevir and Elbasvir in Hepatitis C Genotype 1-Infected Patients With Child-Pugh Cl.

Gastroenterology & hepatology

[No authors listed]

PMID: 26504459 PMCID: PMC4617178

[No abstract available.]

References

  1. N Engl J Med. 2014 Apr 17;370(16):1483-93 - PubMed
  2. Am J Transplant. 2014 Jan;14 Suppl 1:69-96 - PubMed
  3. N Engl J Med. 2014 May 22;370(21):1993-2001 - PubMed
  4. N Engl J Med. 2014 Apr 24;370(17):1604-14 - PubMed
  5. Liver Transpl. 2003 Dec;9(12):1231-43 - PubMed
  6. Lancet. 2014 Feb 8;383(9916):515-23 - PubMed
  7. N Engl J Med. 2013 May 16;368(20):1867-77 - PubMed
  8. N Engl J Med. 2014 May 15;370(20):1889-98 - PubMed
  9. Lancet. 2015 Mar 21;385(9973):1087-97 - PubMed
  10. ChemMedChem. 2013 Dec;8(12):1930-40 - PubMed
  11. ACS Med Chem Lett. 2012 Mar 02;3(4):332-6 - PubMed
  12. N Engl J Med. 2014 May 15;370(20):1879-88 - PubMed
  13. N Engl J Med. 2014 Dec 18;371(25):2375-82 - PubMed
  14. Nature. 2010 May 6;465(7294):96-100 - PubMed
  15. Antimicrob Agents Chemother. 2012 Aug;56(8):4161-7 - PubMed
  16. Gastroenterol Hepatol (N Y). 2015 Jun;11(6 Suppl 3):1-23 - PubMed
  17. N Engl J Med. 2013 May 16;368(20):1878-87 - PubMed
  18. N Engl J Med. 2014 May 22;370(21):1973-82 - PubMed
  19. N Engl J Med. 2014 Apr 24;370(17):1594-603 - PubMed
  20. N Engl J Med. 2014 May 22;370(21):1983-92 - PubMed
  21. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):285-95 - PubMed
  22. Hepatology. 2015 Mar;61(3):769-75 - PubMed
  23. J Med Chem. 2010 Oct 14;53(19):7202-18 - PubMed
  24. Gastroenterology. 2014 Aug;147(2):359-365.e1 - PubMed
  25. Acute Med. 2013;12(4):232-8 - PubMed
  26. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3991-6 - PubMed

Publication Types